Cell and gene therapies are at the forefront of biomedical innovation — offering the potential to treat, prevent, or even cure diseases by addressing their root causes at the cellular or genetic level. At PHCbi, we understand the complexity of these workflows and the need for precision, scalability, and compliance across research and manufacturing.
Purpose-Built Equipment for Cell & Gene Therapy
PHCbi delivers a comprehensive suite of technologies designed to support every stage of cell and gene therapy development — from early research to clinical manufacturing.
*LiCellMo is available for purchase in the U.S., Canada, and select other geographies globally. For research and education use only, not for use in diagnostic procedures in the U.S. or Canada. This product has not been approved or cleared as a medical device by the U.S. Food and Drug Administration or Health Canada.
Why Real-Time Monitoring Matters
Metabolic analysis performed inside a CO2 incubator provides continuous insight into cell health and performance — capturing dynamic changes without disturbing cultures and maintaining optimal in vitro conditions.
Tailored Support for Translational Research
Whether you’re scaling from the bench to the clinic or optimizing complex workflows, PHCbi offers personalized guidance and bundled solutions to accelerate development while ensuring compliance.
Compliance Made Simple
Stay ahead of regulatory requirements with PHCbi's validation services:
- IQ/OQ/PQ documentation and Factory Acceptance Testing (FAT)
- Installation and calibration
- Temperature mapping (loaded & unloaded chamber)
Ready to Advance Your Cell & Gene Therapy Program?
From discovery to clinical manufacturing, PHCbi is your trusted partner for reliable incubation, preservation, monitoring, and imaging.